Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA- alkyltransferase: Phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors

Malcolm Ranson, Mark R. Middleton, John Bridgewater, Siow Ming Lee, Martin Dawson, Debra Jowle, Gavin Halbert, Sue Waller, Helen McGrath, Lindsey Gumbrell, R. Stanley McElhinney, Dorothy Donnelly, T. Brian H McMurry, Geoffrey P. Margison

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA- alkyltransferase: Phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science